Prendio-BioProcure, industry leaders in life science procurement solutions, are proud to announce their latest strategic ...
Inc. (“Zenas” or the “Company”) (Nasdaq: ZBIO), a clinical-stage global biopharmaceutical company committed to being a leader ...
Aileron Therapeutics pulled a hard pivot in 2023, merging with Lung Therapeutics to gain a new pipeline and investor base. | ...
HERZLIYA, Israel and CALGARY, AB, Jan. 29, 2025 /PRNewswire/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in the pharmaceutical ...
Cambium Oncology is pleased to share that their lead drug candidate, ANT308, recently demonstrated outstanding single-agent efficacy and safety in preclinical ...
Initial interim 52-week results from Phase 2b Population Extension cohort of PRISM clinical trial to be presented by Dante Pieramici, M.D., a Principal Investigator in PRISM, at Angiogenesis, ...
Fintel reports that on January 23, 2025, Barclays downgraded their outlook for Galapagos NV - Depositary Receipt () (NasdaqGS:GLPG) from Equal-Weight to Underweight. Analyst Price Forecast Suggests 48 ...
MedSkin Solutions Dr. Suwelack AG is pleased to announce the publication of a new study in the International Wound Journal titled 'Comparison of cell-scaffold interactions in a biological and a ...
LONDON, Jan. 23, 2025 /CNW/ -- Keith Hale has been appointed as Group CEO of Titian Software and Labguru (BioData Inc.), two ...
(NASDAQ:ARGX – Get Free Report)‘s stock had its “buy” rating restated by analysts at Truist Financial in a research report issued on Tuesday,Benzinga reports. They currently have a $700.00 price ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback